Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response

by Jernström S, Hongisto V, Leivonen SK, Due EU, Tadele DS, Edgren H, Kallioniemi O, Perälä M, Mælandsmo GM, Sahlberg KK
Published 2017-03-01